-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
June 01, 2022 - observational studies
Systematic reviews or meta-analyses (evaluating triptans and NSAIDs)
Any sample size
-
digital.ahrq.gov/sites/default/files/docs/citation/cdsic-year-3-report-2024.pdf
January 01, 2024 - outputs, the
CDSiC team developed a suite of companion products to break down complex concepts into bite-size
-
integrationacademy.ahrq.gov/sites/default/files/2025-07/MOUD_Playbook_Environmental_Scan_2025.pdf
January 01, 2025 - However, it is important to understand there is no “one-size-fits-all-approach;” depending on the
characteristics
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - “I'm ready for a trial--but the logistics of a trial and its size make this a hard sell.
-
hcup-us.ahrq.gov/reports/methods/2008_02.pdf
January 01, 2008 - analysis can take into consideration the safety-related practices, staffing
characteristics, culture, size
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-1.pdf
January 31, 2024 - AHRQ EvidenceNOW: Building State Capacity: Interim Evaluation Report I
EvidenceNOW BSC: Interim Evaluation Report I June 2022 ▌1-1
AHRQ EvidenceNOW: Building State Capacity
INTERIM EVALUATION REPORT I
Technical Assistance to and Evaluation of Grant Initiative to Develop State-
Level Capacity f…
-
effectivehealthcare.ahrq.gov/health-topics/adenoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - observational studies
Systematic reviews or meta-analyses (evaluating triptans and NSAIDs)
Any sample size
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 57
Methods for Insulin Delivery and Glucose
Monitoring: Comparative Effectiveness
Executive Summary
Background
Diabetes mellitus is defined as a group
of metabolic diseases characterized by
hyperglycemia resulting from defects
in insulin secretion from the pancreati…